4.3 Article

Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials

期刊

HASTINGS CENTER REPORT
卷 52, 期 3, 页码 9-17

出版社

WILEY
DOI: 10.1002/hast.1391

关键词

consent; pragmatic clinical trials; PCT; respect; clinical ethics; research ethics; bioethics

向作者/读者索取更多资源

This article proposes eight dimensions for demonstrating respect in pragmatic clinical trials, including engaging patients and communities in research design and execution, promoting transparency, maximizing agency, minimizing burdens, protecting privacy, valuing interpersonal interactions, providing compensation, and maximizing social value.
Research ethics oversight systems have traditionally emphasized the informed consent process as the primary means by which to demonstrate respect for prospective subjects. Yet how researchers can best fulfill the ethical obligations of respect for persons in pragmatic clinical trials (PCTs)-particularly those that may alter or waive informed consent-remains unknown. We propose eight dimensions of demonstrating respect in PCTs: (1) engaging patients and communities in research design and execution, (2) promoting transparency and open communication, (3) maximizing agency, (4) minimizing burdens and promoting accessibility, (5) protecting privacy and confidentiality, (6) valuing interpersonal interactions with clinicians and study team members, (7) providing compensation, and (8) maximizing social value. While what respect requires in the context of PCTs will vary based on the nature of the PCT in question, the breadth of these dimensions demonstrates that respect obligations extend beyond informed consent processes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据